Pharmaceutical Technology Europe
It is the end of an era. Building on more than 6 years of dedication and hard work, Gurminder Marwaha has left Pharmaceutical Technology Europe (PTE) in search of new challenges. As his successor, I would like to join all the members of the editorial team in wishing him every success.
It is the end of an era. Building on more than 6 years of dedication and hard work, Gurminder Marwaha has left Pharmaceutical Technology Europe (PTE) in search of new challenges. As his successor, I would like to join all the members of the editorial team in wishing him every success.
And so it is time for change. As the first Spaniard and the first woman to become the Editor of PTE, it is indeed a privilege to be writing this editorial and to assume the editorship of an already successful publication, leader in its sector, and which continues to grow steadily and healthily in readership.
Bibiana Campos-Seijo
I am honoured to be the new Editor of this magazine, especially at such an exciting time. During 2008, PTE will be celebrating its 20th Anniversary, an event that will be commemorated monthly with special features articles that evaluate the last two decades of developments in the pharmaceutical industry.
And with change come fresh ideas and new initiatives and plans, some of which you will see already implemented in this issue or gradually coming into being in forthcoming editions of the magazine. Indeed, in this issue of PTE we are introducing, for the first time, a biopharmaceutical section to reflect the rapid growth and development observed in this field of the pharmaceutical industry. Additionally (and for this issue only!), we are including a section specifically dedicated to Interpack, the largest international trade fair for the packaging industry worldwide, an event that will take place in Germany at the end of this month.
Finally, I would like to thank you, all pharmaceutical technologists across Europe, for your continued support of PTE through the years. It is your support and your contributions that make it the successful magazine that it is. With your input, I look forward to an even brighter future.
Dr Bibiana Campos-Seijo
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.